Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Economic Burden and Main Drivers of Healthcare Resource Utilization in RSV
Focusing on the economic burden of RSV, the panel discusses financial considerations for multiple patient populations, highlighting hospitalization costs and the main drivers of healthcare resource utilization.
EP: 1.Overview of RSV Patient Populations
EP: 2.Complications Associated with RSV Infections
Now Viewing
EP: 3.The Economic Burden and Main Drivers of Healthcare Resource Utilization in RSV
EP: 4.RSV: Risk Factors and How It’s Spread
EP: 5.Diagnostic Practices for RSV
EP: 6.Increasing Awareness of RSV Vaccines in At-Risk Patients
EP: 7.Shared Decision-Making Practices in RSV
EP: 8.Financial and Clinical Benefits of RSV Immunization
EP: 9.The Potential Benefits of RSV Vaccine Approval for Adults Aged 50-59
EP: 10.Addressing Vaccine Fatigue
EP: 11.Identifying Patients Eligible for RSV Vaccine
EP: 12.Current and Potential Obstacles Related to Administering RSV Vaccines
EP: 13.Improving Insurance Coverage for RSV Vaccines
EP: 14.Improving RSV Vaccination Rates and Addressing Misinformation
EP: 15.Key Takeaways on RSV Vaccination
Video content above is prompted by the following questions:
- Please describe the economic burden of RSV, especially in adults aged 50-59 and those 60 and older.
- What are the main drivers of healthcare resource utilization in high-risk patients with RSV?
Related Videos
Related Content
